AFECTA PHARMACEUTICALS INC has a total of 18 patent applications. It decreased the IP activity by 20.0%. Its first patent ever was published in 2009. It filed its patents most often in Canada, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are RADHAKRISHNAN RAMACHANDRAN, TECHFIELDS PHARMA CO LTD and AVEXXIN AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 4 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | United States | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | Israel | 1 | |
#6 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Kovacs Bruce | 16 |
#2 | Nicola George | 7 |
#3 | Shahbahrami Kamron | 7 |
#4 | Pinegar Laura | 5 |
#5 | Bruce Kovacs | 2 |
#6 | Pinegar Laura A | 1 |
#7 | Kamron Shahbahrami | 1 |
#8 | George Nicola | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019241663A1 | Ccl5 inhibitors | |
MX2019014773A | Ccl2 inhibitors. | |
US2020039922A1 | High mobility group b1 protein inhibitors | |
EP3156053A1 | Use of isoindoles for the treatment of neurobehavioral disorders |